No Data
No Data
SprintRay Inc. Announces API Integration With Align Technology's ITero Intraoral Scanners to Further Ease Adoption Into Chairside Digital Dentistry
Mizuho Securities Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $250
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Mizuho Maintains Outperform on Align Technology, Lowers Price Target to $250
Mizuho Adjusts Price Target on Align Technology to $250 From $295, Maintains Outperform Rating
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com